Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02123251 · ClinicalTrials.gov registry record · NA
Hawaii Patient Reward And Incentives to Support Empowerment
A NA study of Diabetes Mellitus, sponsored by University of Hawaii.
- Completed
- Registry status
- NA
- Development phase
- 320
- Enrollment target
- 1
- Study location
NCT02123251: Completed NA study of Diabetes Mellitus, sponsored by University of Hawaii.
NCT02123251 is a NA study of Diabetes Mellitus that has completed, run by University of Hawaii. The registered enrollment target is 320 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02123251, a NA study of Diabetes Mellitus, has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- NA
- Development phase
- 320 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this randomized controlled trial (RCT) study is to examine the extent that financial incentives when combined with diabetes evidence-based practices, improve self-management and biometric measures for adult diabetic Medicaid recipients with an HbA1c of ≥ 6.5 at enrollment. The study will also evaluate the cost-effectiveness of the program. Specific Aims: 1. Evaluate whether financial incentives for completing American Diabetes Association (ADA) recommended tests, exams, health education, biometric outcome goals, and vaccinations will improve primary biometric outcomes. 2. Evaluate whether financial incentives for completing ADA recommended tests, exams, health education, biometric outcome goals, and vaccinations will improve diabetes patients' self-management as assessed by Summary of Diabetes Self-Care Activities Measure (SDSCA) and 36-Item Short Form Health Survey (SF36v2). 3. Evaluate the extent to which financial incentives for healthy behaviors reduce the cost of health care utilization.
Primary Outcome
Changes in Hemoglobin A1c from baseline to end of study. Change = (End of Intervention score - Baseline score)
Conditions Studied
Interventions
- BEHAVIORAL Financial Incentives
Study Locations (1)
Hawaii
- Kaiser Permanente Hawaii - Honolulu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT02123251 record still lists
NCT02123251 is an interventional study that assigns participants to a tested intervention. The registered 320 participants enrollment target is mid-sized for trials with a published cap, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Financial Incentives is the first listed.
NCT02123251 reports a single indexed study location in Hawaii.
Frequently Asked Questions
What is clinical trial NCT02123251 about?
NCT02123251 is a clinical study titled "Hawaii Patient Reward And Incentives to Support Empowerment". The purpose of this randomized controlled trial (RCT) study is to examine the extent that financial incentives when combined with diabetes evidence-based practices, improve self-management and biometric measures for adult diabetic Medicaid recipients with an HbA1c of ≥ 6.5 at enrollment. The study w...
What is the current status of trial NCT02123251?
This trial is currently completed. It is a NA study. The enrollment target is 320 participants. The study started on 2014-05. Estimated completion is 2016-09.
What conditions does trial NCT02123251 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT02123251?
The interventions under investigation include: Financial Incentives (BEHAVIORAL).
Who is sponsoring clinical trial NCT02123251?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02123251 being conducted?
This trial has 1 study location across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02123251's enrollment target sits among peer trials
320 61st of 208 higher than 148 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02763683 · 320 participants
Investigations of Dementia in Parkinson Disease
- NCT03331198 · 320 participants · Phase 1
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
- NCT03458832 · 320 participants
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
- NCT03551951 · 320 participants
Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia